Cardiac Output Monitoring Devices Market Share

  • Report ID: 4217
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Cardiac Output Monitoring Devices Market Share

North American Market Forecast

North America industry is anticipated to account for largest revenue share of 40% by 2037. The growth of the market can be attributed majorly to the increasing frequency of heart diseases, and coronary artery disease in the region. As per the data provided by the Centers for Disease Control and Prevention, in the United States, heart disease accounted for the deaths of about 697,000 people in 2020. Furthermore, coronary artery disease affects nearly 20.1 million adults aged 20 and above. In addition, rising healthcare expenditure and accessibility of technologically advanced equipment are also anticipated to boost the market growth further during the forecast period in the region.

APAC Market Statistics

Furthermore, the Asia Pacific cardiac output monitoring devices market is also projected to display notable market growth by the end of 2037. The growth of the market can be attributed to the escalating prevalence of CVDs, along with the growth in the healthcare infrastructure in the region. For instance, in 2019, CVDs were the major factor responsible for death in Asia, accounting for approximately 11 million deaths in the region. Moreover, surging awareness among people about the CVDs and their treatment is another significant factor that is anticipated to push the market growth further over the projected time frame in the APAC region.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4217
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cardiac output monitoring devices is evaluated at USD 1.15 billion.

The cardiac output monitoring devices market size was valued at USD 1.08 billion in 2024 and is set to exceed USD 1.78 billion by 2037, expanding at over 3.9% CAGR during the forecast period i.e., between 2025-2037. Worldwide increasing elderly population, rising prevalence of chronic obstructive pulmonary disease (COPD), and an upsurge in surgical procedures will boost the market growth.

North America industry is anticipated to account for largest revenue share of 40% by 2037, attributed to increasing frequency of heart diseases, and coronary artery disease in the region.

The major players in the market are ICU Medical, Inc., Schwarzer Cardiotek GmbH, Edwards Lifesciences Corporation, Baxter International, Inc., Deltex Medical plc, CNSystems Medizintechnik GmbH, Abiomed, Inc., Boston Scientific Corporation (BSC), BioTelemetry, Inc., Masimo Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample